Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EpiPen Rival Heads Back To Market After kaléo Retools With ‘100% Automated’ Production

Jan 20 2017

• By Emily Hayes

Related Content

Mylan’s EpiPen Exclusivity Saved Again As Teva Reports CRL

Mar 01 2016

ANDAs For Drug/Device Combos Face High Bar At US FDA; Epipen, Advair May Benefit

Jan 17 2017

EpiPen Generics: Woodcock Explains Injector Studies

Sep 22 2016

EpiPen Outrage In Congress Puts Spotlight On FDA Generic Review

Aug 30 2016

Related Companies

Kaléo Pharmaceutical Inc.

Sanofi

Viatris Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Drug Safety Generic Drugs Pricing Debate BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.